In this second webinar on the topic of canine atopic dermatitis, Dr. Pieper continues his discussion with a focus on moderate to severe cases of disease. His discussion includes:
- Characteristics of moderate to severe disease
- Current therapeutic options including JAK inhibitors (Apoquel and Zenrelia) and when they should be implemented into treatment plans
- The role of monoclonal antibodies and how Cytopoint can be used as part of patient management
- The ideal cases for allergen specific immunotherapy and testing options
Running time: 1 hr 16 mins (including 16 mins of Q&A)
Approved for 1 hour of CE credit by AAVSB RACE and NY State
You might also like
Hemangiosarcoma - What We Know And How That's Changing The Paradigm Of Treatment And Prevention
11/13/2024
Hemangiosarcoma is a malignant tumor and, historically, associated with a poor long term prognosis....
Read
More
Treating Cancer - It's Not Just Limited To "chemo" Or "radiation"
11/06/2024
There are different approaches to cancer treatment and, for some types of cancer, the therapy may be...
Read
More
Cancer Diagnostics - What Is Helpful? What Is Hype Or Truly Offers Hope?
10/30/2024
The mention of 'cancer' can evoke a wide range of emotions ranging from fear to concern to confusion...
Read
More
Protein-Losing Enteropathy - Therapeutic Management And The Crucial Role Of Nutrition
09/17/2024
In this second session (of a two part series) Dr. Jablonski continues the discussion on patient mana...
Read
More
Mastering IMHA In Dogs - Part I: Approaches To Diagnosis And Standard Management
07/23/2024
This is the first of a two part series on the topic of immune-mediated hemolytic anemia (IMHA) in do...
Read
More
Caring For Chronic Kidney Disease (CKD) In The Dog - Quality Of Life And End Of Life Considerations
07/09/2024
The focus of this session is on maximizing the quality of life of dogs with chronic kidney disease (...
Read
More
